NVNO
enVVeno Medical CorpCompany with tickers: NVNO
CIK
1661053
CUSIP
29415J205
Shares Outstanding
667,669
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-12 | Duhay Francis | Director | Sell | 140 |
| 2025-12-16 | Glickman Marc H. | SVP & Chief Medical Officer | Other | 100,000 |
| 2025-12-16 | Glickman Marc H. | SVP & Chief Medical Officer | Other | 1,600 |
| 2025-12-16 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Other | 22,236 |
| 2025-12-16 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Other | 200,000 |
| 2025-12-16 | Alavi Hamed | Chief Technology Officer | Other | 50,000 |
| 2025-12-11 | Duhay Francis | Director | Award | 135,883 |
| 2025-12-11 | Gray Robert | Director | Award | 135,883 |
| 2025-12-11 | Jenusaitis Matthew | Director | Award | 135,883 |
| 2025-12-11 | Shrivastava Sanjay | Director | Award | 135,883 |
| 2025-12-11 | Duhay Francis | Director | Sell | 4,900 |
| 2025-09-15 | Duhay Francis | Director | Sell | 4,900 |
| 2025-05-19 | Bright Jennifer | Chief Financial Officer | Award | 350,000 |
| 2025-05-19 | Bright Jennifer | Chief Financial Officer | Other | 0 |
| 2024-12-31 | Duhay Francis | Director | Buy | 81,433 |
| 2024-12-31 | Gray Robert | Director | Buy | 3,500 |
| 2024-12-24 | Shrivastava Sanjay | Director | Buy | 5,400 |
| 2024-12-19 | Jenusaitis Matthew | Director | Buy | 9,620 |
| 2024-12-19 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Buy | 12,000 |
| 2024-12-18 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Award | 200,000 |
| 2024-12-18 | Duhay Francis | Director | Award | 19,752 |
| 2024-12-18 | Alavi Hamed | Chief Technology Officer | Award | 75,000 |
| 2024-12-18 | Gray Robert | Director | Award | 19,752 |
| 2024-12-18 | Jenusaitis Matthew | Director | Award | 19,752 |
| 2024-12-18 | Shrivastava Sanjay | Director | Award | 19,752 |
| 2024-12-18 | Glickman Marc H. | SVP & Chief Medical Officer | Award | 75,000 |
| 2024-03-13 | Alavi Hamed | Chief Technology Officer | Convert | 8,334 |
| 2024-03-13 | Alavi Hamed | Chief Technology Officer | Convert | 8,334 |
| 2024-03-13 | Alavi Hamed | Chief Technology Officer | Sell | 8,334 |
| 2023-12-05 | Glynn Craig | Chief Financial Officer | Award | 75,000 |
| 2023-12-05 | Gray Robert | Director | Award | 13,856 |
| 2023-12-05 | Jenusaitis Matthew | Director | Award | 13,856 |
| 2023-12-05 | Shrivastava Sanjay | Director | Award | 13,856 |
| 2023-12-05 | Duhay Francis | Director | Award | 13,856 |
| 2023-12-05 | Alavi Hamed | Chief Technology Officer | Award | 100,000 |
| 2023-12-05 | Glickman Marc H. | SVP & Chief Medical Officer | Award | 100,000 |
| 2023-12-05 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Award | 300,000 |
| 2023-01-18 | Alavi Hamed | Chief Technology Officer | Other | 0 |
| 2023-01-18 | Alavi Hamed | Chief Technology Officer | Other | 0 |
| 2023-01-18 | Alavi Hamed | Chief Technology Officer | Other | 0 |
| 2023-01-18 | Alavi Hamed | Chief Technology Officer | Other | 0 |
| 2023-01-18 | Alavi Hamed | Chief Technology Officer | Other | 0 |
| 2022-11-30 | Duhay Francis | Director | Award | 8,403 |
| 2022-11-30 | Shrivastava Sanjay | Director | Award | 8,403 |
| 2022-11-30 | Gray Robert | Director | Award | 8,403 |
| 2022-11-30 | Jenusaitis Matthew | Director | Award | 8,403 |
| 2022-09-13 | Gray Robert | Director | Convert | 1,041 |
| 2022-09-13 | Gray Robert | Director | Convert | 1,041 |
| 2022-09-13 | Jenusaitis Matthew | Director | Convert | 1,041 |
| 2022-09-13 | Jenusaitis Matthew | Director | Convert | 1,041 |
| 2022-08-16 | Duhay Francis | Director | Buy | 7,751 |
| 2022-06-30 | Shrivastava Sanjay | Director | Buy | 1,000 |
| 2022-06-27 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Buy | 2,500 |
| 2021-11-30 | Gray Robert | Director | Award | 7,211 |
| 2021-11-30 | Glynn Craig | Chief Financial Officer | Award | 50,000 |
| 2021-11-30 | Glynn Craig | Chief Financial Officer | Award | 125,925 |
| 2021-11-30 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Award | 200,000 |
| 2021-11-30 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Award | 349,781 |
| 2021-11-30 | Glickman Marc H. | SVP & Chief Medical Officer | Award | 100,000 |
| 2021-11-30 | Glickman Marc H. | SVP & Chief Medical Officer | Award | 265,700 |
| 2021-11-30 | Jenusaitis Matthew | Director | Award | 7,211 |
| 2021-11-30 | Shrivastava Sanjay | Director | Award | 7,211 |
| 2021-11-30 | Duhay Francis | Director | Award | 7,211 |
| 2021-11-19 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Buy | 2,000 |
| 2021-11-16 | Shrivastava Sanjay | Director | Convert | 388 |
| 2021-11-16 | Shrivastava Sanjay | Director | Convert | 388 |
| 2021-11-16 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Buy | 2,000 |
| 2021-09-13 | Jenusaitis Matthew | Director | Convert | 1,042 |
| 2021-09-13 | Jenusaitis Matthew | Director | Convert | 1,042 |
| 2021-09-13 | Gray Robert | Director | Convert | 1,042 |
| 2021-09-13 | Gray Robert | Director | Convert | 1,042 |
| 2021-08-25 | Jenusaitis Matthew | Director | Buy | 1,300 |
| 2021-06-16 | Gray Robert | Director | Buy | 2,000 |
| 2021-05-21 | Glickman Marc H. | SVP & Chief Medical Officer | Buy | 1,600 |
| 2021-05-18 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Buy | 3,000 |
| 2021-05-17 | Duhay Francis | Director | Buy | 9,492 |
| 2021-02-18 | Jenusaitis Matthew | Director | Award | 5,673 |
| 2021-02-18 | Shrivastava Sanjay | Director | Award | 5,673 |
| 2021-02-18 | Glickman Marc H. | SVP & Chief Medical Officer | Award | 406,000 |
| 2021-02-18 | Glynn Craig | Chief Financial Officer | Award | 324,000 |
| 2021-02-18 | Duhay Francis | Director | Award | 5,673 |
| 2021-02-18 | BERMAN ROBERT ANDREW | Director, Chief Executive Officer | Award | 838,000 |
| 2021-02-18 | Gray Robert | Director | Award | 5,673 |
| 2020-08-21 | Biodyne Holding, S.A. | Insider | Sell | 75,000 |
| 2020-08-20 | Biodyne Holding, S.A. | Insider | Sell | 75,000 |
| 2020-08-19 | Biodyne Holding, S.A. | Insider | Sell | 50,000 |
| 2020-08-18 | Biodyne Holding, S.A. | Insider | Sell | 50,000 |
| 2020-08-14 | Biodyne Holding, S.A. | Insider | Sell | 50,000 |
| 2020-08-03 | Biodyne Holding, S.A. | Insider | Sell | 70,000 |
| 2020-07-31 | Biodyne Holding, S.A. | Insider | Sell | 5,000 |
| 2020-07-30 | Biodyne Holding, S.A. | Insider | Sell | 25,000 |
| 2020-07-21 | Biodyne Holding, S.A. | Insider | Sell | 50,000 |
| 2020-07-20 | Biodyne Holding, S.A. | Insider | Sell | 150,000 |
| 2020-07-18 | Jenusaitis Matthew | Director | Award | 100,000 |
| 2020-07-18 | Jenusaitis Matthew | Director | Award | 62,500 |
| 2020-07-18 | Glynn Craig | Chief Financial Officer | Award | 4,000 |
| 2020-07-18 | Gray Robert | Director | Award | 62,500 |
| 2020-07-18 | Gray Robert | Director | Award | 100,000 |
| 2020-07-18 | Duhay Francis | Director | Award | 100,000 |
| 2020-07-18 | Duhay Francis | Director | Award | 62,500 |